-
-
-
-
-
-
-
TransMedics Group (TMDX) Reiterated at Hold by Stifel: Comp Headwinds Ahead
-
-
-
-
-
-
-
Needham Upgrades TransMedics Group (TMDX) to Buy
-
-
-
-
-
-
-
TransMedics gets FDA approval to start heart preservation trial
-
-
-
-
-
-
-
TransMedics Group (TMDX) Tops Q1 EPS by 44c ; Offers Guidance
-
-
-
-
-
-
-
TMDX STOCK UPDATE: TransMedics Group Investors are Reminded to Contact BFA Law before the Expiration of Tomorrow's April 15 Class Action Deadline
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Securities Class Action Against TransMedics Group, Inc. (TMDX)
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Reminds Investors That It Has Filed a Securities Class Action Against TransMedics Group, Inc. (TMDX)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

